138
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Circulating Bone-Specific Alkaline Phosphatase and Abdominal Aortic Calcification in Maintenance Hemodialysis Patients

, , , &
Pages 1231-1239 | Received 18 Mar 2018, Accepted 28 Jun 2018, Published online: 30 Nov 2018

References

  • Bellasi A , BlockGA, FerramoscaE, RattiC, RaggiP. Integration of clinical and imaging data to predict death in hemodialysis patients. Hemodial. Int.17, 12 – 18 (2013).
  • Jean G , MayorB, DeleavalPet al. Vascular calcification progression is an independent predictor of mortality in patients on haemodialysis. Nephron130, 169 – 174 (2015).
  • Criqui MH , DenenbergJO, McClellandRLet al. Abdominal aortic calcium, coronary artery calcium, and cardiovascular morbidity and mortality in the multi-ethnic study of atherosclerosis. Arterioscler. Thromb. Vasc. Biol.34, 1574 – 1579 (2014).
  • Bellasi A , FerramoscaE, MuntnerPet al. Correlation of simple imaging tests and coronary artery calcium measured by computed tomography in hemodialysis patients. Kidney Int.70, 1623 – 1628 (2006).
  • Raggi P , BellasiA, FerramoscaEet al. Association of pulse wave velocity with vascular and valvular calcification in hemodialysis patients. Kidney Int.71, 802 – 807 (2007).
  • Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD work group . KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int. Suppl.113, S1 – S130 (2009).
  • Sardiwal S , MagnussonP, GoldsmithDJ, LambEJ. Bone alkaline phosphatase in CKD-mineral bone disorder. Am. J. Kidney Dis.62, 810 – 822 (2013).
  • Lomashvili KA , GargP, NarisawaS, MillanJL, O’NeillWC. Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: potential mechanism for uremic vascular calcification. Kidney Int.73, 1024 – 1030 (2008).
  • Kobayashi I , ShidaraK, OkunoSet al. Higher serum bone alkaline phosphatase as a predictor of mortality in male hemodialysis patients. Life Sci.90, 212 – 218 (2012).
  • Iba K , TakadaJ, YamashitaT. The serum level of bone-specific alkaline phosphatase activity is associated with aortic calcification in osteoporosis patients. J. Bone Miner. Metab.22, 594 – 596 (2004).
  • Mikumo M , OkanoH, YoshikataR, IshitaniK, OhtaH. Association between lumbar bone mineral density and vascular stiffness as assessed by pulse wave velocity in postmenopausal women. J. Bone Miner. Metab.27, 89 – 94 (2009).
  • Kauppila LI , PolakJF, CupplesLA, HannanMT, KielDP, WilsonPW. New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study. Atherosclerosis132, 245 – 250 (1997).
  • Verbeke F , Van BiesenW, HonkanenEet al. Prognostic value of aortic stiffness and calcification for cardiovascular events and mortality in dialysis patients: outcome of the calcification outcome in renal disease (CORD) study. Clin. J. Am. Soc. Nephrol.6, 153 – 159 (2011).
  • Peres LA , PércioPP. Mineral and bone disorder and vascular calcification in patients with chronic kidney disease. J. Bras. Nefrol.36, 201 – 207 (2014).
  • Shaheen FA , KurpadR, Al-SayyariAAet al. Multinational observational study on clinical practices and therapeutic management of mineral and bone disorders in patients with chronic kidney disease stages 4, 5, and 5D: the OCEANOS study. Saudi. J. Kidney Dis. Transpl.27, 290 – 304 (2016).
  • Shroff R , LongDA, ShanahanC. Mechanistic insights into vascular calcification in CKD. J. Am. Soc. Nephrol.24, 179 – 189 (2013).
  • Moe SM , ChenNX. Pathophysiology of vascular calcification in chronic kidney disease. Circ. Res.95, 560 – 567 (2004).
  • Moe SM , O’NeillKD, DuanDet al. Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int.61, 638 – 647 (2002).
  • Schoppet M , ShanahanCM. Role for alkaline phosphatase as an inducer of vascular calcification in renal failure?Kidney Int.73, 989 – 991 (2008).
  • Shantouf R , KovesdyCP, KimYet al. Association of serum alkaline phosphatase with coronary artery calcification in maintenance hemodialysis patients. Clin. J. Am. Soc. Nephrol.4, 1106 – 1114 (2009).
  • Lehmann G , OttU, KaemmererD, SchuetzeJ, WolfG. Bone histomorphometry and biochemical markers of bone turnover in patients with chronic kidney disease stages 3–5. Clin. Nephrol.70, 296 – 305 (2008).
  • Haarhaus M , ArnqvistHJ, MagnussonP. Calcifying human aortic smooth muscle cells express different bone alkaline phosphatase isoforms, including the novel B1x isoform. J. Vasc. Res.50, 167 – 174 (2013).
  • O’Neill WC , SigristMK, McIntyreCW. Plasma pyrophosphate and vascular calcification in chronic kidney disease. Nephrol. Dial. Transplant.25, 187 – 191 (2010).
  • Anderson HC , SipeJB, HessleLet al. Impaired calcification around matrix vesicles of growth plate and bone in alkaline phosphatase-deficient mice. Am. J. Pathol.164, 841 – 847 (2004).
  • Fahrleitner-Pammer A , HerberthJ, BrowningSRet al. Bone markers predict cardiovascular events in chronic kidney disease. J. Bone Miner. Res.23, 1850 – 1858 (2008).
  • Drechsler C , VerduijnM, PilzSet al. Bone alkaline phosphatase and mortality in dialysis patients. Clin. J. Am. Soc. Nephrol.6, 1752 – 1759 (2011).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.